Leave a little sharper than you arrived.

News, calculators, learning and daily puzzles — pick any one and leave a little further along.

Today’s puzzle

Diabetes drugs for Alzheimer's: promising biology, disappointing trials, and a pivot to prevention

Could blood sugar drugs slow Alzheimer's? The science looked promising, but the biggest test yet — Novo Nordisk's phase 3 EVOKE trials of oral semaglutide in nearly 3,800 patients — showed no meaningful slowing of cognitive decline. Researchers are now shifting focus toward earlier intervention and prevention-based strategies, including the new $100M PROTECT-Cog global trial.

Axios · 2 min

The U.S. officially loses measles elimination status for the first time in decades

OncLive · 2 min

PET scans catch glioma treatment responses faster than MRI in vorasidenib-treated patients

news-medical.net · 3 min

A tiny DNA switch may hold the secret to what makes the human brain unique

Everything on Curie.MD

NeurologyPlay & LearnLearn what’s new in your field, a few minutes at a time.Start learning CardiologyCalculatorsEnter the case once. See every relevant score, side by side.Open a calculator All fieldsDaily GamesThree new clinical puzzles every morning.Play today

Get Curie’s Weekly Dose

What changed in clinical practice, policy, and coverage, and what it means for your patients.

Subscribe free Free. Weekly. Unsubscribe anytime.